Skip to content
Disclosery

Rhenman & Partners Asset Management AB

Follow

13F filer, CIK 1599882, Stockholm, Sweden

Rhenman & Partners Asset Management AB reported $903,668,707 across 92 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-13. Its ten largest share positions make up 30.09% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001213900-25-109534

Period
2025-09-30
Reported value
$904M
Holdings
92
Top 10 weight
30.09%
New
13
Sold out
11

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ABBVadded+61,000$14.1M
BSXadded+142,000$13.9M
UNHadded+32,100$11.1M
AXSMadded+82,000$9.96M
TMOadded+18,900$9.17M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
THCreduced-78,000-$15.8M
DXCMexited-159,500-$13.9M
HCAexited-29,778-$11.4M
VERONA PHARMA PLCexited-106,500-$10.1M
GILDreduced-88,000-$9.77M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001213900-25-109534, largest first. % of portfolio is the value over $903,668,707, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 590,000 shares; 2024Q4: 444,000 shares; 2025Q1: 300,000 shares; 2025Q2: 296,000 shares; 2025Q3: 438,000 shares 438,000$42.8M4.73%+142,000Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 47,500 shares; 2024Q4: 45,450 shares; 2025Q1: 41,750 shares; 2025Q2: 57,870 shares; 2025Q3: 53,420 shares 53,420$40.8M4.51%-4,450Timeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 177,000 shares; 2024Q4: 124,150 shares; 2025Q1: 88,650 shares; 2025Q2: 69,375 shares; 2025Q3: 130,375 shares 130,375$30.2M3.34%+61,000Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 83,302 shares; 2024Q4: 63,952 shares; 2025Q1: 41,952 shares; 2025Q2: 121,452 shares; 2025Q3: 134,452 shares 134,452$26.7M2.95%+13,000Timeline
ALHCALIGNMENT HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,977,363 shares; 2024Q4: 1,761,192 shares; 2025Q1: 1,337,284 shares; 2025Q2: 1,287,284 shares; 2025Q3: 1,479,284 shares 1,479,284$25.8M2.86%+192,000Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 63,000 shares; 2024Q4: 64,000 shares; 2025Q1: 51,500 shares; 2025Q2: 44,350 shares; 2025Q3: 48,500 shares 48,500$21.7M2.4%+4,150Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 72,700 shares; 2024Q4: 60,530 shares; 2025Q1: 77,430 shares; 2025Q2: 30,430 shares; 2025Q3: 62,530 shares 62,530$21.6M2.39%+32,100Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 122,600 shares; 2024Q4: 122,600 shares; 2025Q1: 109,600 shares; 2025Q2: 90,800 shares; 2025Q3: 172,800 shares 172,800$21M2.32%+82,000Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 184,000 shares; 2024Q4: 267,500 shares; 2025Q1: 235,862 shares; 2025Q2: 295,362 shares; 2025Q3: 277,362 shares 277,362$20.9M2.31%-18,000Timeline
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 30,117 shares; 2024Q4: 34,117 shares; 2025Q1: 47,217 shares; 2025Q2: 27,717 shares; 2025Q3: 26,600 shares 26,600$20.5M2.27%-1,117Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 39,000 shares; 2024Q4: 43,457 shares; 2025Q1: 31,750 shares; 2025Q2: 27,700 shares; 2025Q3: 36,100 shares 36,100$20.3M2.25%+8,400Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 195,000 shares; 2024Q4: 212,500 shares; 2025Q1: 81,000 shares; 2025Q2: 182,000 shares; 2025Q3: 310,000 shares 310,000$20.3M2.24%+128,000Timeline
MDTMEDTRONIC PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 368,000 shares; 2024Q4: 269,500 shares; 2025Q1: 255,000 shares; 2025Q2: 179,500 shares; 2025Q3: 205,000 shares 205,000$19.5M2.16%+25,500Timeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 45,150 shares; 2024Q4: 53,750 shares; 2025Q1: 32,375 shares; 2025Q2: 49,375 shares; 2025Q3: 62,375 shares 62,375$19.5M2.16%+13,000Timeline
EXASEXACT SCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 465,000 shares; 2024Q4: 471,000 shares; 2025Q1: 440,000 shares; 2025Q2: 350,000 shares; 2025Q3: 348,000 shares 348,000$19M2.11%-2,000Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 129,513 shares; 2024Q4: 61,500 shares; 2025Q1: 185,500 shares; 2025Q2: 175,435 shares; 2025Q3: 131,885 shares 131,885$19M2.1%-43,550Timeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 111,000 shares; 2024Q4: 36,531 shares; 2025Q1: 270,000 shares; 2025Q2: 235,000 shares; 2025Q3: 230,000 shares 230,000$18.8M2.08%-5,000Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 47,750 shares; 2024Q4: 50,000 shares; 2025Q1: 66,750 shares; 2025Q2: 61,455 shares; 2025Q3: 46,955 shares 46,955$18.4M2.03%-14,500Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,000 shares; 2024Q4: 57,000 shares; 2025Q1: 61,000 shares; 2025Q2: 46,000 shares; 2025Q3: 58,000 shares 58,000$17.9M1.98%+12,000Timeline
COOCOOPER COS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 228,000 shares; 2024Q4: 115,000 shares; 2025Q1: 236,000 shares; 2025Q2: 170,000 shares; 2025Q3: 237,000 shares 237,000$16.2M1.8%+67,000Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 71,750 shares; 2024Q4: 100,317 shares; 2025Q1: 89,817 shares; 2025Q2: 149,217 shares; 2025Q3: 114,717 shares 114,717$16.1M1.78%-34,500Timeline
EHCENCOMPASS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 61,000 shares; 2024Q4: 56,000 shares; 2025Q1: 37,400 shares; 2025Q2: 136,400 shares; 2025Q3: 119,400 shares 119,400$15.2M1.68%-17,000Timeline
CAHCARDINAL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 55,000 shares; 2025Q3: 94,000 shares 94,000$14.8M1.63%+39,000Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,100 shares; 2024Q4: 15,640 shares; 2025Q1: 12,640 shares; 2025Q2: 11,140 shares; 2025Q3: 30,040 shares 30,040$14.6M1.61%+18,900Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50,350 shares; 2024Q4: 17,000 shares; 2025Q1: 48,197 shares; 2025Q2: 51,197 shares; 2025Q3: 31,875 shares 31,875$14.5M1.61%-19,322Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 180,500 shares; 2024Q4: 149,250 shares; 2025Q1: 104,250 shares; 2025Q2: 104,250 shares; 2025Q3: 255,250 shares 255,250$14M1.55%+151,000Timeline
PRCTPROCEPT BIOROBOTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 445,000 shares; 2024Q4: 420,345 shares; 2025Q1: 448,000 shares; 2025Q2: 190,000 shares; 2025Q3: 390,000 shares 390,000$13.9M1.54%+200,000Timeline
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 41,685 shares; 2024Q4: 78,385 shares; 2025Q1: 28,200 shares; 2025Q2: 32,000 shares; 2025Q3: 46,500 shares 46,500$13.4M1.48%+14,500Timeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 135,000 shares; 2024Q4: 128,000 shares; 2025Q1: 52,000 shares; 2025Q2: 58,500 shares; 2025Q3: 98,500 shares 98,500$13.2M1.46%+40,000Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 93,000 shares; 2024Q4: 145,500 shares; 2025Q1: 124,300 shares; 2025Q2: 109,030 shares; 2025Q3: 95,030 shares 95,030$12.5M1.39%-14,000Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 55,000 shares; 2025Q3: 155,000 shares 155,000$12.1M1.33%+100,000Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 221,400 shares; 2024Q4: 197,700 shares; 2025Q1: 126,700 shares; 2025Q2: 136,429 shares; 2025Q3: 58,429 shares 58,429$11.9M1.31%-78,000Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 92,500 shares; 2025Q2: 197,600 shares; 2025Q3: 230,600 shares 230,600$10.9M1.21%+33,000Timeline
ALGNALIGN TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 55,000 shares; 2024Q4: 41,900 shares; 2025Q1: 41,500 shares; 2025Q2: 66,500 shares; 2025Q3: 83,000 shares 83,000$10.4M1.15%+16,500Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 364,500 shares; 2024Q4: 250,623 shares; 2025Q1: 265,000 shares; 2025Q2: 149,650 shares; 2025Q3: 186,650 shares 186,650$10.1M1.12%+37,000Timeline
DOCSDOXIMITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 21,000 shares; 2025Q3: 136,000 shares 136,000$9.95M1.1%+115,000Timeline
RPRXROYALTY PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 613,500 shares; 2024Q4: 595,000 shares; 2025Q1: 411,000 shares; 2025Q2: 344,000 shares; 2025Q3: 258,500 shares 258,500$9.12M1.01%-85,500Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 366,500 shares; 2024Q4: 255,500 shares; 2025Q1: 233,500 shares; 2025Q2: 168,150 shares; 2025Q3: 80,150 shares 80,150$8.9M0.98%-88,000Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 259,500 shares; 2024Q4: 232,000 shares; 2025Q1: 433,000 shares; 2025Q2: 574,000 shares; 2025Q3: 574,000 shares 574,000$8.83M0.98%0Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 15,300 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,250 shares 18,250$8.37M0.93%newTimeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 67,100 shares; 2024Q4: 123,700 shares; 2025Q1: 49,500 shares; 2025Q2: 12,000 shares; 2025Q3: 55,000 shares 55,000$7.7M0.85%+43,000Timeline
DVAXDYNAVAX TECHNOLOGIES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,190,000 shares; 2024Q4: 839,131 shares; 2025Q1: 565,000 shares; 2025Q2: 565,000 shares; 2025Q3: 772,000 shares 772,000$7.67M0.85%+207,000Timeline
ADPTADAPTIVE BIOTECHNOLOGIES CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 495,000 shares 495,000$7.41M0.82%newTimeline
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50,500 shares; 2024Q4: 23,150 shares; 2025Q1: 48,950 shares; 2025Q2: 44,650 shares; 2025Q3: 22,500 shares 22,500$7.27M0.8%-22,150Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 150,000 shares; 2024Q4: 114,000 shares; 2025Q1: 126,627 shares; 2025Q2: 126,627 shares; 2025Q3: 173,627 shares 173,627$6.83M0.76%+47,000Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 165,000 shares 165,000$6.26M0.69%newTimeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 116,982 shares; 2024Q4: 195,482 shares; 2025Q1: 126,000 shares; 2025Q2: 99,757 shares; 2025Q3: 170,000 shares 170,000$6.07M0.67%+70,243Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 250,000 shares 250,000$5.88M0.65%newTimeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 102,500 shares; 2024Q4: 90,000 shares; 2025Q1: 100,000 shares; 2025Q2: 85,000 shares; 2025Q3: 216,288 shares 216,288$5.68M0.63%+131,288Timeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,290,000 shares; 2025Q2: 1,250,763 shares; 2025Q3: 1,250,763 shares 1,250,763$5.63M0.62%0Timeline
ACLXARCELLX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 32,000 shares; 2024Q4: 43,500 shares; 2025Q1: 43,500 shares; 2025Q2: 67,250 shares; 2025Q3: 65,250 shares 65,250$5.36M0.59%-2,000Timeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 367,500 shares; 2024Q4: 195,591 shares; 2025Q1: 28,250 shares; 2025Q2: 93,250 shares; 2025Q3: 232,250 shares 232,250$5.26M0.58%+139,000Timeline
PENPENUMBRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,200 shares; 2025Q2: 21,500 shares; 2025Q3: 20,500 shares 20,500$5.19M0.57%-1,000Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 70,000 shares; 2025Q2: 135,100 shares; 2025Q3: 180,100 shares 180,100$5.04M0.56%+45,000Timeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 79,500 shares; 2024Q4: 74,500 shares; 2025Q1: 74,500 shares; 2025Q2: 116,000 shares; 2025Q3: 53,500 shares 53,500$5.04M0.56%-62,500
BRKRBRUKER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 44,315 shares; 2024Q4: 36,315 shares; 2025Q1: 42,315 shares; 2025Q2: 123,315 shares; 2025Q3: 154,315 shares 154,315$5.01M0.55%+31,000Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 231,000 shares; 2024Q4: 123,410 shares; 2025Q1: 138,500 shares; 2025Q2: 57,500 shares; 2025Q3: 31,000 shares 31,000$4.99M0.55%-26,500Timeline
PRVAPRIVIA HEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 95,189 shares; 2024Q4: 121,189 shares; 2025Q1: 98,189 shares; 2025Q2: 91,189 shares; 2025Q3: 194,189 shares 194,189$4.84M0.54%+103,000Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 90,000 shares; 2024Q4: 72,500 shares; 2025Q1: 52,500 shares; 2025Q2: 52,500 shares; 2025Q3: 52,500 shares 52,500$4.54M0.5%0Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 122,000 shares; 2024Q4: 150,041 shares; 2025Q1: 16,000 shares; 2025Q2: 30,500 shares; 2025Q3: 61,000 shares 61,000$4.53M0.5%+30,500Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 166,526 shares; 2024Q4: 314,526 shares; 2025Q1: 195,000 shares; 2025Q2: 250,000 shares; 2025Q3: 490,000 shares 490,000$4.34M0.48%+240,000Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 105,000 shares; 2024Q4: 73,755 shares; 2025Q1: 73,755 shares; 2025Q2: 65,755 shares; 2025Q3: 56,255 shares 56,255$4.12M0.46%-9,500Timeline
RDNTRADNET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 46,000 shares; 2025Q3: 50,000 shares 50,000$3.81M0.42%+4,000Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 130,000 shares 130,000$3.78M0.42%newTimeline
IQVIQVIA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 48,000 shares; 2024Q4: 29,000 shares; 2025Q1: 22,000 shares; 2025Q2: 13,000 shares; 2025Q3: 19,500 shares 19,500$3.7M0.41%+6,500Timeline
VCELVERICEL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 58,000 shares; 2025Q3: 117,000 shares 117,000$3.68M0.41%+59,000Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 82,000 shares; 2025Q2: 93,100 shares; 2025Q3: 119,400 shares 119,400$3.59M0.4%+26,300Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 51,000 shares; 2024Q4: 52,750 shares; 2025Q1: 35,750 shares; 2025Q2: 35,870 shares; 2025Q3: 35,870 shares 35,870$3.54M0.39%0Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 35,000 shares 35,000$3.53M0.39%newTimeline
TGTXTG THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 171,500 shares; 2024Q4: 262,500 shares; 2025Q1: 177,500 shares; 2025Q2: 115,000 shares; 2025Q3: 93,000 shares 93,000$3.36M0.37%-22,000Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 8,000 shares 8,000$3.35M0.37%newTimeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 35,000 shares; 2024Q4: 35,000 shares; 2025Q1: 35,000 shares; 2025Q2: 35,000 shares; 2025Q3: 81,000 shares 81,000$3.25M0.36%+46,000Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 300,000 shares; 2024Q4: 290,000 shares; 2025Q1: 249,336 shares; 2025Q2: 185,000 shares; 2025Q3: 347,500 shares 347,500$3.21M0.36%+162,500Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares 50,000$3.12M0.35%newTimeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 133,000 shares; 2024Q4: 77,999 shares; 2025Q1: 39,000 shares; 2025Q2: 39,000 shares; 2025Q3: 94,000 shares 94,000$2.82M0.31%+55,000Timeline
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 53,000 shares; 2025Q3: 53,000 shares 53,000$2.78M0.31%0Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 560,000 shares; 2024Q4: 542,500 shares; 2025Q1: 460,000 shares; 2025Q2: 460,000 shares; 2025Q3: 823,000 shares 823,000$2.51M0.28%+363,000Timeline
UHSUNIVERSAL HLTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,000 shares; 2024Q4: 30,900 shares; 2025Q1: not reported; 2025Q2: 26,000 shares; 2025Q3: 12,000 shares 12,000$2.45M0.27%-14,000Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 106,847 shares; 2024Q4: 170,000 shares; 2025Q1: 141,627 shares; 2025Q2: 55,127 shares; 2025Q3: 100,127 shares 100,127$2.45M0.27%+45,000Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 460,000 shares; 2024Q4: 460,000 shares; 2025Q1: 460,000 shares; 2025Q2: 460,000 shares; 2025Q3: 460,000 shares 460,000$2.4M0.27%0Timeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,052,500 shares; 2024Q4: 1,235,448 shares; 2025Q1: 647,827 shares; 2025Q2: 647,827 shares; 2025Q3: 1,097,827 shares 1,097,827$2.38M0.26%+450,000Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 202,000 shares 202,000$2.36M0.26%newTimeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 17,000 shares; 2024Q4: 23,750 shares; 2025Q1: 17,750 shares; 2025Q2: 12,750 shares; 2025Q3: 11,750 shares 11,750$2.07M0.23%-1,000Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 203,750 shares; 2024Q4: 195,750 shares; 2025Q1: 195,750 shares; 2025Q2: 165,750 shares; 2025Q3: 165,750 shares 165,750$1.94M0.22%0Timeline
BTSGBRIGHTSPRING HEALTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 60,000 shares 60,000$1.77M0.2%newTimeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 45,000 shares; 2025Q2: 45,000 shares; 2025Q3: 207,000 shares 207,000$1.48M0.16%+162,000Timeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 100,000 shares; 2025Q2: 100,000 shares; 2025Q3: 100,000 shares 100,000$1.45M0.16%0Timeline
STVNSTEVANATO GROUP S P AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 51,000 shares 51,000$1.31M0.15%newTimeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 7,000 shares 7,000$1.2M0.13%newTimeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 58,278 shares; 2024Q4: 58,278 shares; 2025Q1: 28,278 shares; 2025Q2: 28,278 shares; 2025Q3: 28,278 shares 28,278$1.03M0.11%0Timeline
TECHBIO-TECHNE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 20,000 shares; 2024Q4: 3,000 shares; 2025Q1: not reported; 2025Q2: 15,000 shares; 2025Q3: 15,000 shares 15,000$834K0.09%0Timeline
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,000 shares 18,000$262K0.03%newTimeline

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
DXCMDEXCOM INC159,500$13.9Mshares
HCAHCA HEALTHCARE INC29,778$11.4Mshares
VERONA PHARMA PLCVERONA PHARMA PLC106,500$10.1Mshares
OSCROSCAR HEALTH INC312,092$6.69Mshares
MOHMOLINA HEALTHCARE INC22,200$6.61Mshares
ALCALCON AG68,000$5.99Mshares
ASTHASTRANA HEALTH INC190,000$4.73Mshares
SYKSTRYKER CORPORATION11,500$4.55Mshares
RGENREPLIGEN CORP19,500$2.43Mshares
SMMTSUMMIT THERAPEUTICS INC78,000$1.66Mshares
INMBINMUNE BIO INC178,284$412Kshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001213900-25-109534 base2025-11-13acceptance time not in the bulk data set